Your search returned 73 results.

Results
	61.	The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells. [electronic resource] by Kim, J H Seibel, M M MacLaughlin, D T Donahoe, P K Ransil, B J Hametz, P A Richards, C J Producer: 19921008 In: The Journal of clinical endocrinology and metabolism vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	62.	Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivo. [electronic resource] by Segev, D L Hoshiya, Y Stephen, A E Hoshiya, M Tran, T T MacLaughlin, D T Donahoe, P K Maheswaran, S Producer: 20010823 In: The Journal of biological chemistry vol. 276 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	63.	Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. [electronic resource] by Silberstein, T MacLaughlin, D T Shai, I Trimarchi, J R Lambert-Messerlian, G Seifer, D B Keefe, D L Blazar, A S Producer: 20060227 In: Human reproduction (Oxford, England) vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	64.	Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. [electronic resource] by Lee, M M Donahoe, P K Silverman, B L Hasegawa, T Hasegawa, Y Gustafson, M L Chang, Y C MacLaughlin, D T Producer: 19970522 In: The New England journal of medicine vol. 336 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	65.	Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content. [electronic resource] by Seifer, D B MacLaughlin, D T Penzias, A S Behrman, H R Asmundson, L Donahoe, P K Haning, R V Flynn, S D Producer: 19930405 In: The Journal of clinical endocrinology and metabolism vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	66.	Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway. [electronic resource] by Segev, D L Ha, T U Tran, T T Kenneally, M Harkin, P Jung, M MacLaughlin, D T Donahoe, P K Maheswaran, S Producer: 20001013 In: The Journal of biological chemistry vol. 275 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	67.	Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells. [electronic resource] by Lee, M M Seah, C C Masiakos, P T Sottas, C M Preffer, F I Donahoe, P K Maclaughlin, D T Hardy, M P Producer: 19990603 In: Endocrinology vol. 140 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	68.	Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressor. [electronic resource] by Donahoe, P K Cate, R L MacLaughlin, D T Epstein, J Fuller, A F Takahashi, M Coughlin, J P Ninfa, E G Taylor, L A Producer: 19871014 In: Recent progress in hormone research vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	69.	Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. [electronic resource] by Lee, M M Donahoe, P K Hasegawa, T Silverman, B Crist, G B Best, S Hasegawa, Y Noto, R A Schoenfeld, D MacLaughlin, D T Producer: 19960708 In: The Journal of clinical endocrinology and metabolism vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	70.	Developmental expression of a candidate müllerian inhibiting substance type II receptor. [electronic resource] by Teixeira, J He, W W Shah, P C Morikawa, N Lee, M M Catlin, E A Hudson, P L Wing, J Maclaughlin, D T Donahoe, P K Producer: 19960205 In: Endocrinology vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	71.	Müllerian inhibiting substance as a marker for ovarian sex-cord tumor. [electronic resource] by Gustafson, M L Lee, M M Scully, R E Moncure, A C Hirakawa, T Goodman, A Muntz, H G Donahoe, P K MacLaughlin, D T Fuller, A F Producer: 19920221 In: The New England journal of medicine vol. 326 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	72.	The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. [electronic resource] by Gu, Z Reynolds, E M Song, J Lei, H Feijen, A Yu, L He, W MacLaughlin, D T van den Eijnden-van Raaij, J Donahoe, P K Li, E Producer: 19990707 In: Development (Cambridge, England) vol. 126 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	73.	Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. [electronic resource] by Masiakos, P T MacLaughlin, D T Maheswaran, S Teixeira, J Fuller, A F Shah, P C Kehas, D J Kenneally, M K Dombkowski, D M Ha, T U Preffer, F I Donahoe, P K Producer: 20000106 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 5 Availability: No items available. Save to lists Add to cart (remove)